| 81420 | The lab analyst performs a genomic sequence analysis panel to evaluate circulating cell free fetal DNA in maternal blood for genetic sequences of at least the genes on chromosomes 13, 18, and 21,… | 2 | 10 | 4,900 | $390 | $2.2M |
| 81479 | Use 81479 to report a molecular pathology procedure that does not have a specific code. | 3 | 10 | 830 | $850 | $620.4K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 3 | 30 | 5,480 | $60 | $581.1K |
| 81408 | The lab analyst performs the technical lab test to complete one of the specific genetic analyses listed in this Tier 2, Level 9 molecular pathology code. | 1 | 10 | 230 | $100 | $378.4K |
| 81220 | The lab analyst performs the technical lab test to detect the presence of changes in the gene for cystic fibrosis transmembrane conductance regulator, also known as CFTR. The test evaluates the CFTR… | 1 | 10 | 620 | $200 | $374.6K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 7 | 50 | 4,960 | $20 | $273.9K |
| 81162 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the BRCA1, DNA repair–associated gene, also called BRCA1; and BRCA2, DNA repair–associated gene, also called… | 1 | 10 | 900 | $260 | $236.1K |
| 81251 | The lab analyst performs the technical lab test to detect the presence of specific changes in the gene for glucosidase, beta, acid, also known as GBA. | 1 | 10 | 9,250 | $20 | $175.3K |
| 83080 | The lab analyst measures the amount of the beta–hexosaminidase A or B that is present, typically in a serum specimen. These two enzymes are deficient in conditions such as Tay–Sachs disease or… | 1 | 10 | 9,750 | $20 | $167.1K |
| 81422 | The lab analyst performs a genomic sequence analysis panel to evaluate circulating cell–free fetal DNA in maternal blood for chromosomal microdeletion(s) associated with conditions such as DiGeorge… | 1 | 10 | 1,470 | $110 | $162.8K |